Artwork

Inhoud geleverd door MTPConnect. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door MTPConnect of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.
Player FM - Podcast-app
Ga offline met de app Player FM !

Trials & Tribulations - Developing the World-First Oxford AstraZeneca COVID-19 Vaccine

29:14
 
Delen
 

Manage episode 307778350 series 3009792
Inhoud geleverd door MTPConnect. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door MTPConnect of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

Dr Maheshi Ramasamy is a Principal Investigator at the Oxford Vaccine Group where she leads on adult clinical vaccine trials including the Oxford AstraZeneca COVID-19 vaccine trials. Dr Ramasamy joins the podcast from the UK to take us through the challenges of developing a successful international clinical trial against the clock during a fast-moving pandemic, her experiences as a clinician scientist working on the frontline in UK COVID hospital wards and the impact of securing approval for the vaccine. MTPConnect co-hosts MD and CEO Dr Dan Grant and COO Stuart Dignam chat to Dr Ramasamy about concerns over vaccine safety, rare adverse events, vaccine hesitancy and fake news. Dr Ramasamy, an Australian Sri Lankan, shares her motivations and research interests. She also explains how her international career pathway – including working at Australia's Ballarat Base Hospital - helped her to pursue this challenge of a lifetime. Dr Ramasamy is also a Consultant Physician at Oxford University Hospitals NHS Foundation Trust, the Deputy Director of the Graduate Entry Medicine course at Oxford and the Florey Lecturer at Oxford’s Magdalen College.

  continue reading

171 afleveringen

Artwork
iconDelen
 
Manage episode 307778350 series 3009792
Inhoud geleverd door MTPConnect. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door MTPConnect of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

Dr Maheshi Ramasamy is a Principal Investigator at the Oxford Vaccine Group where she leads on adult clinical vaccine trials including the Oxford AstraZeneca COVID-19 vaccine trials. Dr Ramasamy joins the podcast from the UK to take us through the challenges of developing a successful international clinical trial against the clock during a fast-moving pandemic, her experiences as a clinician scientist working on the frontline in UK COVID hospital wards and the impact of securing approval for the vaccine. MTPConnect co-hosts MD and CEO Dr Dan Grant and COO Stuart Dignam chat to Dr Ramasamy about concerns over vaccine safety, rare adverse events, vaccine hesitancy and fake news. Dr Ramasamy, an Australian Sri Lankan, shares her motivations and research interests. She also explains how her international career pathway – including working at Australia's Ballarat Base Hospital - helped her to pursue this challenge of a lifetime. Dr Ramasamy is also a Consultant Physician at Oxford University Hospitals NHS Foundation Trust, the Deputy Director of the Graduate Entry Medicine course at Oxford and the Florey Lecturer at Oxford’s Magdalen College.

  continue reading

171 afleveringen

Alle afleveringen

×
 
Loading …

Welkom op Player FM!

Player FM scant het web op podcasts van hoge kwaliteit waarvan u nu kunt genieten. Het is de beste podcast-app en werkt op Android, iPhone en internet. Aanmelden om abonnementen op verschillende apparaten te synchroniseren.

 

Korte handleiding